TMCnet News
Research and Markets: A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market - 2015Research and Markets (http://www.researchandmarkets.com/research/r3l6hk/a_competitive) has announced the addition of the "A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market " report to their offering. This research service offers an assessment for marketed and pipeline products for the global ACS (News - Alert) therapeutics market. Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are broadly segmented into anti-platelet therapeutics, anti-hypertensives and cholesterol lowering drugs, anti-thrombins, and others. Other upcoming therapies include anti-inflammatories. The forecast period is 2015-2025. Among the various classes of ACS therapeutics, anti-hypertensives and cholesterol lowering drugs are currently dominating the ACS therapeutics market with an influx of new drugs targeting novel pathways. The key drug targets include the proprotein convertase subtilisin/kexin type 9 (PCSK9) and cholesteryl ester transfer protein (CETP). GSK has so far recruited patients for this trials to evaluate the safety of the drug in reducing the risk of cardiovascular events such as death, heart attack, or near heart attack that require urgent treatment. The enzyme p38 kinase is known for its role in inflammation and its inhibition is expected to stabilize atherosclerotic plaques and reduce plaque rupture thereby preventing thrombosis. Sanofi and Regeneron has recently received a priority review certificate for its lead drug Praluent (alirocumab) an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). So far, ten Phase 3 clinical trials, including ODYSSEY OUTCOMES, will include over patients. Companies Mentioned: - Amgen - Bayer - Bristol Myers Squibb - Eli Lilly and Co. - GlaxoSmithKline - Merck & Co. - Regeneron - Sanofi - The Medicines Company For more information visit http://www.researchandmarkets.com/research/r3l6hk/a_competitive About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on businesswire.com: http://www.businesswire.com/news/home/20150610005914/en/ |
